UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Breast cancer mortality in Norway after the introduction of mammography screening

International journal of cancer, 2013-01, Vol.132 (1), p.208-214

2013

Volltextzugriff (PDF)

The potential for prevention of colorectal cancer in the UK

European journal of cancer prevention, 2009-06, Vol.18 (3), p.179-190

2009

Volltextzugriff (PDF)

Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study

BMJ, 2005-01, Vol.330 (7485), p.220

International edition, 2005

Volltextzugriff (PDF)

Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database

International Journal of Obesity, 2021-06, Vol.45 (6), p.1249-1258

2021

Volltextzugriff (PDF)

Investigating the potential non‐authorized use of two different formulations of liraglutide in Europe: A real‐world drug utilization study

Diabetes, obesity & metabolism, 2023-04, Vol.25 (4), p.985-991

2023

Volltextzugriff (PDF)

Obesity, cardiovascular risk and healthcare resource utilization in the UK

European journal of preventive cardiology, 2021-09, Vol.28 (11), p.1235-1241

2021

Volltextzugriff (PDF)

Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study

Journal of managed care & specialty pharmacy, 2021-02, Vol.27 (2), p.210-222

2021

Volltextzugriff (PDF)

Overdiagnosis in screening mammography in Denmark: population based cohort study

BMJ (Online), 2013-02, Vol.346 (feb26 1), p.f1064-f1064

International edition, 2013

Volltextzugriff (PDF)

Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

Advances in therapy, 2022-08, Vol.39 (8), p.3735-3748

2022

Volltextzugriff (PDF)

Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark

Breast cancer research and treatment, 2020-12, Vol.184 (3), p.891-899

2020

Volltextzugriff (PDF)

Screening opportunity bias in case-control studies of cancer screening

Journal of applied statistics, 2008-05, Vol.35 (5), p.537-546

2008

Volltextzugriff (PDF)

Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes

Acta oncologica, 2006, Vol.45 (5), p.528-535

2006

Volltextzugriff (PDF)

Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

Advances in therapy, 2023, Vol.40 (1), p.389-390

2023

Volltextzugriff (PDF)

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England

Journal of medical screening, 2010-01, Vol.17 (1), p.25-30

2010

Volltextzugriff (PDF)

A model for determining the effect of mammography service screening

Acta oncologica, 2005-03, Vol.44 (2), p.120-128

2005

Volltextzugriff (PDF)

Mammography activity in Norway 1983 to 2008

Acta oncologica, 2011-10, Vol.50 (7), p.1062-1067

2011

Volltextzugriff (PDF)

Socio‐demographic determinants of participation in mammography screening

International journal of cancer, 2008-01, Vol.122 (2), p.418-423

2008

Volltextzugriff (PDF)

Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER

Journal of the Endocrine Society, 2023-05, Vol.7 (6), p.bvad054

2023

Volltextzugriff (PDF)

Obesity, cardiovascular risk and healthcare resource utilization in the UK

European journal of preventive cardiology, 2020-05, p.2047487320925639

2020

Volltextzugriff (PDF)

Author's reply: Breast cancer mortality in Norway after the introduction of mammography screening

International journal of cancer, 2013-04, Vol.132 (7), p.1727-1727

2013

Volltextzugriff (PDF)

Is there an association between liraglutide use and female breast cancer in a real-world setting?

Diabetes, metabolic syndrome and obesity, 2018-01, Vol.11, p.791-806

2018

Volltextzugriff (PDF)

Estimating the Benefits of Mammography Screening: The Impact of Study Design

Epidemiology (Cambridge, Mass.), 2007-07, Vol.18 (4), p.487-492

2007

Volltextzugriff (PDF)

Predicting the risk of a false-positive test for women following a mammography screening programme

Journal of medical screening, 2007-06, Vol.14 (2), p.94-97

2007

Volltextzugriff (PDF)

Overdiagnosis, Sojourn Time, and Sensitivity in the Copenhagen Mammography Screening Program

The breast journal, 2006-07, Vol.12 (4), p.338-342

2006

Volltextzugriff (PDF)

Breast cancer incidence after the introduction of mammography screening : What should be expected?

Cancer, 2006-05, Vol.106 (9), p.1883-1890

2006

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(44)
Humans
(41)
Female
(34)
Middle Aged
(28)
Aged
(24)
Mammography
(20)
Oncology
(16)
Denmark - Epidemiology
(14)
Breast Cancer
(12)
Breast Neoplasms - Diagnostic Imaging
(12)
Adult
(11)
Biological And Medical Sciences
(10)
Mortality
(10)
Breast Neoplasms - Diagnosis
(9)
Breast Neoplasms - Epidemiology
(9)
Breast Neoplasms - Mortality
(9)
Male
(9)
Medical Sciences
(9)
Risk Factors
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Breast cancer mortality in Norway after the introduction of mammography screening

The potential for prevention of colorectal cancer in the UK

Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study

Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database

Investigating the potential non‐authorized use of two different formulations of liraglutide in Europe: A real‐world drug utilization study

Obesity, cardiovascular risk and healthcare resource utilization in the UK

Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study

Overdiagnosis in screening mammography in Denmark: population based cohort study

Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark

Screening opportunity bias in case-control studies of cancer screening

Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes

Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England

A model for determining the effect of mammography service screening

Mammography activity in Norway 1983 to 2008

Socio‐demographic determinants of participation in mammography screening

Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER

Obesity, cardiovascular risk and healthcare resource utilization in the UK

Author's reply: Breast cancer mortality in Norway after the introduction of mammography screening

Is there an association between liraglutide use and female breast cancer in a real-world setting?

Estimating the Benefits of Mammography Screening: The Impact of Study Design

Predicting the risk of a false-positive test for women following a mammography screening programme

Overdiagnosis, Sojourn Time, and Sensitivity in the Copenhagen Mammography Screening Program

Breast cancer incidence after the introduction of mammography screening : What should be expected?

Suchergebnisse filtern